We further reported that LYAR promotes tumor cell migration and invasion by directly binding to the LYAR-binding motif (CTAACC; reverse complement GGTTAG) in the LGALS1 promoter to activate its expression in CRC cells [20]. The gene discussed is LGALS1; the disease is neoplasm.